Ji Chengjie, Zhang Nan, Damaraju Sambasivarao, Damaraju Vijaya L, Carpenter Pat, Cass Carol E, Li Liang
Department of Chemistry, University of Alberta, Cross Cancer Institute, Edmonton, Alberta, Canada T6G 2G2.
Anal Chim Acta. 2007 Mar 7;585(2):219-26. doi: 10.1016/j.aca.2006.12.054. Epub 2007 Jan 13.
The combination of dimethylation after guanidination (2MEGA) isotope labeling with microbore liquid chromatography (LC)-matrix-assisted laser desorption ionization (MALDI) MS and MS/MS [C. Ji, N. Guo, L. Li, J. Proteome Res. 4 (2005) 2099] has been reported as a promising strategy for abundance ratio-dependent quantitative proteome analysis. A critical step in using this integrated strategy is to set up the abundance ratio threshold of peptide pairs, above which the peptide pairs are used for quantifying and identifying the protein that is considered to be differentially expressed between two different samples. The threshold is determined by technical variation (i.e., the overall abundance ratio variation caused by the experimental process including sample workup, MS analysis and data processing) as well as biological variation (i.e., the abundance ratio variation caused by the biological process including cell growth), which can be defined and assessed by a coefficient of variation (CV). We have designed experiments and measured three different levels of variations, starting with the same membrane protein preparation, the same batch of cells and three batches of cells from the same cell line grown under the same conditions, respectively. It is shown that technical variation from the experimental processes involved in 2MEGA labeling LC-MALDI MS has a CV of <15%. In addition, the measured biological variation from cell growth was much smaller than the measured technical variation. From the studies of the occurrence rate of outliers in the distribution of the abundance ratio data within a comparative dataset of peptide pairs, it is concluded that, to compare the proteome changes between two sets of cultured cells without the use of replicate experiments, a relative abundance ratio of greater than 2X or less than 0.5X (X is the average abundance ratio of the dataset) on peptide pairs can be used as a stringent threshold to quantify and identify differentially expressed proteins with high confidence.
胍基化后二甲基化(2MEGA)同位素标记与微径液相色谱(LC)-基质辅助激光解吸电离(MALDI)质谱和串联质谱联用[C. Ji,N. Guo,L. Li,J. Proteome Res. 4 (2005) 2099]已被报道为一种用于基于丰度比的定量蛋白质组分析的有前景的策略。使用这种综合策略的关键步骤是设定肽对的丰度比阈值,高于该阈值的肽对用于定量和鉴定被认为在两个不同样品之间差异表达的蛋白质。该阈值由技术变异(即由包括样品处理、质谱分析和数据处理在内的实验过程引起的总体丰度比变异)以及生物学变异(即由包括细胞生长在内的生物学过程引起的丰度比变异)决定,这可以通过变异系数(CV)来定义和评估。我们设计了实验并测量了三种不同水平的变异,分别从相同的膜蛋白制备物、同一批次的细胞以及在相同条件下培养的来自同一细胞系的三批次细胞开始。结果表明,2MEGA标记LC-MALDI MS所涉及的实验过程中的技术变异的CV<15%。此外,测得的细胞生长生物学变异远小于测得的技术变异。从肽对比较数据集中丰度比数据分布中的异常值发生率研究得出结论,为了在不使用重复实验的情况下比较两组培养细胞之间的蛋白质组变化,肽对的相对丰度比大于2X或小于0.5X(X是数据集的平均丰度比)可作为严格阈值,用于高置信度地定量和鉴定差异表达的蛋白质。